Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Beggs, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Beggs, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Use of a Two-Armed Zymark(r) Robot for High Throughput Screening

Mark Beggs

Lead Discovery Department, ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG United Kingdom

High throughput screening is a key component of the pharmaceutical lead identification process at ZENECA. Robotic systems have been employed throughout the industry to perform (i) both the initial compound dilution and distribution processes that form a common "front end" to many high throughput screens and (ii) the assay assembly and signal detection steps that comprise an individual screen. Although the use of manipulative arm systems in formulating and replicating test compounds is well established, robotic throughput rates have been significantly slower than those that can be maintained by human operatives and, consequently, the use of robots for performing assays has been limited. In recent years, the industry has experienced significant increases in the rate of compound screening and throughput rates are now approaching the upper limit that human operatives can be expected to achieve in a working day. To permit future increases in our rate of screening we have designed a novel automation system, based on the use of two Zymark(r) arms. The rationale behind automation of the screening process, the capabilities provided by the system, and the resulting benefits are described.

Journal of Biomolecular Screening, Vol. 2, No. 2, 71-78 (1997)
DOI: 10.1177/108705719700200204


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?